LUNG ADENOCARCINOMA
Clinical trials for LUNG ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for LUNG ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo tested for Tough-to-Treat lung cancers
Disease control CompletedThis early-stage trial tested a combination of two existing drugs, auranofin and sirolimus, for patients with advanced or returning lung cancer who had no other standard treatments left. The main goals were to find the safest dose and see if the drugs could slow the cancer's grow…
Matched conditions: LUNG ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Diabetes drug added to lung cancer treatment in groundbreaking trial
Disease control CompletedThis study tested whether adding the common diabetes medication metformin to standard chemotherapy and radiation could better control stage III non-small cell lung cancer. Researchers randomly assigned 170 patients with inoperable lung cancer to receive either the standard treatm…
Matched conditions: LUNG ADENOCARCINOMA
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC